Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
Financial release and supplemental presentation accessible online
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at
Conference Call and Webcast Information:
- Registration: Click here to register. Upon registration, participants will receive dial-in details and a personalized PIN. While not required, joining 10 minutes prior to the event start time is recommended.
- Live webcast: Access here or through the Investor Relations section of the Haemonetics website.
A replay of the conference call and webcast will be available beginning at
Earnings Materials:
Haemonetics has also posted the following materials on its Investor Relations website, which will be referenced during the conference call and webcast:
- Fourth Quarter Fiscal 2026 Earnings Release
- Fourth Quarter Fiscal 2026 Supplemental Earnings Presentation
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts:
(781) 356-9763
olga.guyette@haemonetics.com
David Trenk, Manager-Investor Relations
(203) 733-4987
david.trenk@haemonetics.com
Media Contact:
(781) 356-9776
josh.gitelson@haemonetics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-corporation-announces-fourth-quarter-fiscal-2026-financial-results-available-on-investor-relations-website-302764893.html
SOURCE
